These findings are also in contrast to BDNF, which has been primarily shown to promote the formation of mature, stubby spines [34,58], although one study demonstrates that a TrkB agonist increases thin spine density in a mouse model of Alzheimer’s Disease [59]. This evidence concerns the gene BDNF and early-onset autosomal dominant Alzheimer disease.